Andrew Pitts
Psychiatry · Lewes, DENPI 1851464689
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 227 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,898, more than ten times the $63 reported in 2019. Among psychiatry clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $21.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$918
- Johnson & Johnson$832
- Alkermes, Inc.$564
- AbbVie$446
- Vanda Pharmaceuticals Inc.$438
- Neurocrine Biosciences, Inc.$419
- plus $1K from 6 others
What the payments were for
- Food & beverage$4,74995%
- Education$2295%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 35 | $918 |
| Johnson & Johnson | 38 | $832 |
| Alkermes, Inc. | 32 | $564 |
| AbbVie(2 entities) | 20 | $446 |
| Vanda Pharmaceuticals Inc. | 17 | $438 |
| Neurocrine Biosciences, Inc. | 19 | $419 |
| E.r. Squibb & Sons, L.L.C. | 16 | $363 |
| Otsuka America Pharmaceutical, Inc. | 16 | $325 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $310 |
| Lundbeck LLC | 12 | $237 |
| Abiomed | 2 | $94 |
| Indivior Inc. | 2 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$108
How this compares
$4,977 in reported general payments places this provider in the 95th percentile of 114 psychiatry providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega TrinzaPaliperidone Palmitate | 23 | $253,726 |
| Invega SustennaPaliperidone Palmitate | 58 | $177,378 |
| Abilify MaintenaAripiprazole | 33 | $80,982 |
| AristadaAripiprazole Lauroxil | 20 | $78,928 |
| VraylarCariprazine Hcl | 38 | $51,710 |
| LybalviOlanzapine/Samidorphan Malate | 29 | $44,857 |
| Lurasidone Hcl | 87 | $15,684 |
| Divalproex Sodium ErDivalproex Sodium | 143 | $11,529 |
| Aripiprazole | 61 | $8,709 |
| Olanzapine | 258 | $7,134 |
| Quetiapine Fumarate | 172 | $6,598 |
| Chlorpromazine Hcl | 24 | $6,476 |
| Atomoxetine Hcl | 45 | $6,368 |
| Clozapine | 76 | $6,206 |
| Duloxetine Hcl | 56 | $4,833 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Trinza, Invega Sustenna | $832 | $431,10481 claims |
| Alkermes, Inc.Aristada, Lybalvi | $564 | $123,78549 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $325 | $80,98233 claims |
| AbbVieVraylar | $446 | $51,71038 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 114 psychiatry providers in Delaware.
Other psychiatry in Lewes
- Melody BensonLewes$786
- Rebecca MontanaLewes$729
- Ranganathan RamWilmington$202K
- Manisha WadhwaWilmington$89K
- Vishesh AgarwalWilmington$46K
- Anis AhmedMillsboro$8K
- Dilipkumar JoshiNewark$6K
- Jeet JoshiNewark$5K
- Kathlyn RowenWilmington$5K
- Alexander JacobsonNewark$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.